Today, Pfizer Inc. Expected to Earn FY2017 Earnings of $2.67 Per Share (PFE)

Today, Pfizer Inc. Expected to Earn FY2017 Earnings of $2.67 Per Share (PFE)

Pfizer Inc. (NYSE:PFE) – Analysts at Jefferies Group dropped their FY2017 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday. Jefferies Group analyst J. Holford now anticipates that the brokerage will post earnings of $2.67 per share for the year, down from their previous forecast of $2.71. Jefferies Group has a “Hold” rating and a $36.00 price target on the stock. Jefferies Group also issued estimates for Pfizer’s FY2018 earnings at $2.92 EPS, FY2019 earnings at $2.87 EPS and FY2020 earnings at $3.08 EPS.

Pfizer (NYSE:PFE) last released its quarterly earnings data on Tuesday, August 2nd. The biopharmaceutical company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.02. Pfizer had a net margin of 14.88% and a return on equity of 23.37%. The company earned $13.10 billion during the quarter, compared to analyst estimates of $13.01 billion. During the same period last year, the business earned $0.56 earnings per share. Pfizer’s revenue was up 10.9% compared to the same quarter last year.

Other equities analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. set a $40.00 target price on shares of Pfizer and gave the company a “buy” rating in a research note on Wednesday, August 3rd. Sanford C. Bernstein set a $38.00 target price on shares of Pfizer and gave the company a “buy” rating in a research note on Tuesday, August 2nd. Piper Jaffray Cos. set a $54.00 target price on shares of Pfizer and gave the company a “buy” rating in a research note on Monday, July 25th. BMO Capital Markets restated a “buy” rating and set a $40.00 target price on shares of Pfizer in a research note on Thursday, July 21st. Finally, Vetr lowered shares of Pfizer from a “strong-buy” rating to a “buy” rating and set a $37.28 price target for the company. in a research report on Tuesday, June 28th. Eleven investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $38.63.

Pfizer (NYSE:PFE) traded up 0.754% during trading on Monday, hitting $32.745. 5,089,118 shares of the stock were exchanged. Pfizer has a 1-year low of $28.25 and a 1-year high of $37.39. The company has a 50-day moving average price of $33.96 and a 200 day moving average price of $34.35. The firm has a market capitalization of $198.62 billion, a price-to-earnings ratio of 29.029 and a beta of 0.86.

Hedge funds have recently modified their holdings of the company. Capital Investment Advisors LLC raised its stake in Pfizer by 1.7% in the third quarter. Capital Investment Advisors LLC now owns 186,723 shares of the biopharmaceutical company’s stock worth $6,324,000 after buying an additional 3,071 shares during the last quarter. Hengehold Capital Management LLC raised its stake in Pfizer by 1.5% in the third quarter. Hengehold Capital Management LLC now owns 61,389 shares of the biopharmaceutical company’s stock worth $2,079,000 after buying an additional 906 shares during the last quarter. Ipswich Investment Management Co. Inc. raised its stake in Pfizer by 8.5% in the third quarter. Ipswich Investment Management Co. Inc. now owns 32,914 shares of the biopharmaceutical company’s stock worth $1,115,000 after buying an additional 2,585 shares during the last quarter. DORCHESTER WEALTH MANAGEMENT Co raised its stake in Pfizer by 20.3% in the third quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 146,235 shares of the biopharmaceutical company’s stock worth $4,953,000 after buying an additional 24,681 shares during the last quarter. Finally, American National Bank raised its stake in Pfizer by 5.5% in the third quarter. American National Bank now owns 169,772 shares of the biopharmaceutical company’s stock worth $5,750,000 after buying an additional 8,894 shares during the last quarter. Institutional investors own 69.66% of the company’s stock.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 1st. Investors of record on Friday, November 11th will be given a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, November 8th. This represents a $1.20 dividend on an annualized basis and a yield of 3.69%. Pfizer’s dividend payout ratio is presently 95.24%.

Pfizer Company Profile

Related posts

Leave a Comment